What if the biopharmaceutical industry could eliminate the need for cold chain logistics saving the industry billions of dollars every year? What if products such as, genetic materials, attenuated viruses, viral vectors, biologics, antibodies, biosimilars, protein subunits, nanosuspensions, small and large molecular actives, combination products, medical devices, etc. could all be stable, stored, and transported at room temperature or at normal refrigeration in hotter climates?
The answer to solve this global problem is Hyalo Technologies’ Sterilization Method and the Hyalo Matrix. Cold chain logistics could be eliminated by improving product stability and allowing for room temperature storage and transport.